GV (Google Ventures) portfolio AI companies

Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes. Our dream is to provide life-long cures for patients suffering from serious diseases.The Beam Team Is:•A community of fearless innovators•Rigorous and honest in our research•Listening with open minds•Committed to each other

• Post-IPO debt
• 600 employees
• Founded 2017

At Vir Biotechnology, Inc., we leverage the immense potential of the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer.We focus on the therapeutic areas in which we believe we can most benefit patients. Our foundational efforts in chronic hepatitis delta are complemented by strategic programs in oncology. Every day, we work with the utmost urgency to deliver potentially transformative medicines for patients.Our pipeline is built on two technology platforms which enable us to rapidly identify, optimize and advance candidates from concepts to the clinic: our next-generation antibody platform and our protease-releasable masking platform in infectious disease and cancer. Explore our full pipeline here: https://bit.ly/3tr7FPmIt has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir Bio's recruiting process: https://bit.ly/461EgJN

• Post-IPO equity
• 458 employees
• Founded 2016

Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease

• Series B
• 440 employees
• Founded 2021

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

• Post-IPO equity
• 411 employees
• Founded 2014

Vera Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing treatments for serious immunological diseases to improve patients’ lives.Fraud alert for potential candidates for positions at Vera: your personal information and online safety are a top priority for us. At Vera Therapeutics, recruiters will only direct candidates to apply through our official career page at https://veratx.com/careers/. We will never request payments, ask for financial account information or sensitive information such as social security numbers. If you are unsure if a message is from Vera Therapeutics, please email hr@veratx.com.Unfortunately, sometimes we have to pull comments made on our page. Here are some reasons why that could be:* Your comment references a product (ours or someone else's)* Your comment references a side effect* Your comment contains vulgarity* Your comment contains medical advice* Your comment is off-topic

• Post-IPO equity
• 365 employees
• Founded 2016